GHK-Cu / KPV Blend Transdermal

This formulation combines two well-characterized bioactive peptides: GHK-Cu (glycyl-L-histidyl-L-lysine:copper(II)), a naturally occurring copper-binding tripeptide with established roles in tissue remodeling, antioxidant gene upregulation, and dermal fibroblast activation; and KPV (α-MSH C-terminal tripeptide Lys-Pro-Val), a potent anti-inflammatory peptide that antagonizes NF-κB signaling and modulates intestinal and cutaneous inflammatory cascades. The transdermal co-formulation enables simultaneous delivery of both peptides for research into synergistic wound healing, skin barrier restoration, and localized inflammation resolution in ex vivo and in vivo models.

Molecular Information

GHK-Cu CAS	49557-75-7
GHK-Cu Formula	C₁₄H₂₄CuN₆O₄
GHK-Cu MW	340.84 g/mol
KPV CAS	69631-26-1
KPV Formula	C₁₆H₃₁N₃O₄
KPV MW	329.44 g/mol
Purity (each)	≥98% (HPLC)
Appearance	Blue-green (GHK-Cu) / white (KPV) lyophilized powders
Storage Form	Blended lyophilized peptide / transdermal solution

Storage Information

Store blended material in a cool refrigerated environment to protect from degradation.  Protect from UV light and oxidizing conditions to preserve copper chelation integrity.

Quality Assurance & Supplier Commitment

We maintain longstanding relationships with leading peptide lyophilizers and raw material suppliers, selected through an exhaustive vetting process that evaluates manufacturing practices, analytical capabilities, and regulatory compliance. Our API sourcing protocol includes certificate of analysis review, third-party analytical testing, and periodic supplier audits to ensure consistent purity, potency, and sterility standards across all product lines.

Each batch undergoes meticulous quality control verification prior to release, including HPLC purity analysis, mass spectrometry confirmation, and endotoxin testing where applicable. Our commitment to sourcing integrity ensures researchers receive material of the highest available quality.